Lifeboat Foundation

For over five decades, futurist Raymond Kurzweil has shown a propensity for understanding how computers can change our world. Now he’s ready to anoint nanorobots as the key to allowing humans to transcend life’s ~120-year threshold.

As he wrote—both in the upcoming The Singularity is Nearer book (set for release on June 25) and in an essay published in Wired —the merging of biotechnology with artificial intelligence will lead to nanotechnology helping “overcome the limitations of our biological organs altogether.”

As our bodies accumulate errors when cells reproduce over and over, it invites damage. That damage can get repaired quickly by young bodies, but less so when age piles up.

We’ve now been living with COVID for well over four years. Although there’s still much to learn about SARS-CoV-2 (the virus that causes COVID) at least one thing seems clear: it’s here to stay.

From the original Wuhan variant, to delta, to omicron, and several others in between, the virus has continued to evolve.

New variants have driven repeated waves of infection and challenged doctors and scientists seeking to understand this changing virus’ behavior.

Researchers in Budapest have been studying worms to slow down or stop ageing in humans by researching transposable elements in our DNA.

Today I’m thrilled to announce BrainBridge, the world’s first concept for a head transplant system, which integrates advanced robotics and artificial intelligence to execute complete head and face transplantation procedures. This state-of-the-art system offers new hope to patients suffering from untreatable conditions such as stage-4 cancer, paralysis, and neurodegenerative diseases like Alzheimer’s and Parkinson’s.

Official website: https://brainbridge.tech/
Follow me everywhere: https://muse.io/hashemalghaili.

Continue reading “Head Transplant Machine — BrainBridge” »

A Stanford Medicine study reveals six subtypes of depression, identified through brain imaging and machine learning. These subtypes exhibit unique brain activity patterns, helping predict which patients will benefit from specific antidepressants or behavioral therapies. This approach aims to personalize and improve depression treatment efficacy.

In the not-too-distant future, a quick brain scan during a screening assessment for depression could identify the best treatment.

According to a new study led by researchers at Stanford Medicine, brain imaging combined with a type of AI called machine learning can reveal subtypes of depression and anxiety. The study, to be published today (June 17) in the journal Nature Medicine, sorts depression into six biological subtypes, or “biotypes,” and identifies treatments that are more likely or less likely to work for three of these subtypes.

Researchers have discovered sex-specific differences in the nerve cells that generate pain, paving the way for personalized pain management treatments based on patient sex.

Research indicates that men and women experience pain differently, but the reasons behind this have remained unclear. A new study from the University of Arizona Health Sciences, published in the journal BRAIN, has now identified functional sex differences in nociceptors, the specialized nerve cells that produce pain.

The findings support the implementation of a precision medicine-based approach that considers patient sex as fundamental to the choice of treatment for managing pain.

A synthetic skin for prosthetics limbs that can generate its own energy from solar power has been developed by engineers from Glasgow University.

Researchers had already created an ‘electronic skin’ for prosthetic hands made with new super-material graphene.

The new skin was much more sensitive to touch but needed a power source to operate its sensors.

Scientists have discovered that CAR T cells, traditionally used in cancer treatment, can be engineered to fight aging by eliminating senescent cells, offering a promising single-dose, lifelong treatment against aging-related diseases.

The fountain of youth has eluded explorers for ages. It turns out the magic anti-aging elixir might have been inside us all along.

Cold Spring Harbor Laboratory (CSHL) Assistant Professor Corina Amor Vegas and colleagues have discovered that T cells can be reprogrammed to fight aging, so to speak. Given the right set of genetic modifications, these white blood cells can attack another group of cells known as senescent cells. These cells are thought to be responsible for many of the diseases we grapple with later in life.

IceCure Medical, an Israeli company that developed a way to freeze and destroy tumors (cryoablation) as alternative to surgery, says an interim analysis of its current kidney cancer trial shows the platform is a safe and effective treatment for malignant renal tumors, with 89.5 percent recurrence-free rate.

The data from the analysis for the trial of the ProSense platform was presented at the Annual Israeli Conference on Interventional Radiology in Tel Aviv on June 10.

Cryoablation is not a new process, but IceCure’s system allows physicians to perform the procedure at their own office, with no need for hospitalization. It also uses liquid nitrogen instead of a mixture of argon and helium gasses, which is cheaper, can be frozen faster, and is easier to maintain at sub-zero temperatures, shortening the treatment time.